Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: LMP Real Estate Income Fund Inc. Portfolio Composition as of March 31, 2013 to Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes

This site contains about 74,006 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   600   700   800   900   1,000   1,100   1,200   1,300   1,400   1,520   1,530   1,540   1,550   1,560   1,570   1,580   1,590   1,600   1,609   1,610   1,611   1,612   1,613   1,614   1,615   1,616   1,617   1,618   1,619   1,620   1,621   1,622   1,623   1,624   1,625   1,626   1,627   1,628   1,629   1,630   1,631   1,632   1,633   1,634   1,635   1,636   1,637   1,638   1,640   1,650   1,660   1,670   1,680   1,690   1,700   1,710   1,720   1,800   1,900   2,000   2,100   2,200   2,300   2,400   2,467 

2013/4/29
LMP Real Estate Income Fund Inc. Portfolio Composition as of March 31, 2013
LMP Real Estate Income Fund Inc. (NYSE: RIT) announces its portfolio composition as of March 31, 2013.
View more LMP Real Estate Income Fund Inc. Portfolio Composition as of March 31, 2013 analysis
Sign-up for LMP Real Estate Income Fund Inc. Portfolio Composition as of March 31, 2013 investment picks
2013/4/29
100,000 New Users Join Virtual Piggy
Virtual Piggy, Inc. (OTCBB: VPIG) , an innovator in safe youth payments, today announced that the company has seen 100,000 new active users sign-up for the Virtual Piggy youth wallet solution since March.
View more 100,000 New Users Join Virtual Piggy analysis
Sign-up for 100,000 New Users Join Virtual Piggy investment picks
2013/4/29
Meritage Homes Presentation to be Webcast on May 9, 2013 from Wells Fargo Industrial and Construction Conference
SCOTTSDALE, Ariz.
View more Meritage Homes Presentation to be Webcast on May 9, 2013 from Wells Fargo Industrial and Construction Conference analysis
Sign-up for Meritage Homes Presentation to be Webcast on May 9, 2013 from Wells Fargo Industrial and Construction Conference investment picks
2013/4/29
Ormat Signs 20-Year Power Purchase Agreement for its Wild Rose Geothermal Project in Nevada
RENO, Nev.
View more Ormat Signs 20-Year Power Purchase Agreement for its Wild Rose Geothermal Project in Nevada analysis
Sign-up for Ormat Signs 20-Year Power Purchase Agreement for its Wild Rose Geothermal Project in Nevada investment picks
2013/4/29
Deckers Outdoor Announces Participation in the Barclays 2013 Retail & Consumer Discretionary Conference
Deckers Outdoor Corporation (NASDAQ: DECK) today announced that the Company will make a presentation at the Barclays 2013 Retail & Consumer Discretionary Conference in New York City.
View more Deckers Outdoor Announces Participation in the Barclays 2013 Retail & Consumer Discretionary Conference analysis
Sign-up for Deckers Outdoor Announces Participation in the Barclays 2013 Retail & Consumer Discretionary Conference investment picks
2013/4/29
Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer
Teva Pharmaceutical Industries Ltd.
View more Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer analysis
Sign-up for Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer investment picks
2013/4/29
Insperity Announces First Quarter Results
Insperity, Inc. (NYSE: NSP) , a leading provider of human resources and business performance solutions for America’s best businesses, today reported first quarter net income of $13.2 million and diluted earnings per share of $0.51. Revenues for the first quarter of 2013 increased 2.8% over the first quarter of 2012 due to a 1.2% increase in the average number of worksite employees paid per month and a 1.6% increase in revenues per worksite employee per month.
View more Insperity Announces First Quarter Results analysis
Sign-up for Insperity Announces First Quarter Results investment picks
2013/4/29
Omega Protein To Present At The Baird Growth Stock Conference
HOUSTON , April 29, 2013 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME) , a nutritional product company and a leading integrated producer of omega-3 fish oil and specialty protein products, today announced Andrew Johannesen , Executive Vice President & Chief Financial Officer, will present at the Baird Growth Stock Conference Thursday, May 9, 2013 at 11:20 a.m. ET in Chicago, IL.
View more Omega Protein To Present At The Baird Growth Stock Conference analysis
Sign-up for Omega Protein To Present At The Baird Growth Stock Conference investment picks
2013/4/29
PROS to Showcase Big Data Applications for Pricing and Sales Effectiveness at Professional Pricing Society Spring Conference
PROS ® (NYSE: PRO) , a big data software company, today announced its participation in the 24th annual Professional Pricing Society (PPS) workshops and conference .
View more PROS to Showcase Big Data Applications for Pricing and Sales Effectiveness at Professional Pricing Society Spring Conference analysis
Sign-up for PROS to Showcase Big Data Applications for Pricing and Sales Effectiveness at Professional Pricing Society Spring Conference investment picks
2013/4/29
Legg Mason BW Global Income Opportunities Fund Inc. Portfolio Composition as of March 31, 2013
Legg Mason BW Global Income Opportunities Fund Inc. (NYSE: BWG) announces its portfolio composition as of March 31, 2013.
View more Legg Mason BW Global Income Opportunities Fund Inc. Portfolio Composition as of March 31, 2013 analysis
Sign-up for Legg Mason BW Global Income Opportunities Fund Inc. Portfolio Composition as of March 31, 2013 investment picks
2013/4/29
Tenneco Reports First Quarter Results
Tenneco Inc. (NYSE: TEN) reported first quarter net income of $54 million, or 88-cents per diluted share, compared with $30 million, or 49-cents per diluted share in first quarter 2012.
View more Tenneco Reports First Quarter Results analysis
Sign-up for Tenneco Reports First Quarter Results investment picks
2013/4/29
FX Energy Reports Gas Flow at Tuchola-3K Well; Production Test to Start
SALT LAKE CITY , April 29, 2013 /PRNewswire/ -- FX Energy, Inc. (NASDAQ: FXEN) today reported results of a drill stem test (DST) on the Tuchola-3K well in north-central Poland .
View more FX Energy Reports Gas Flow at Tuchola-3K Well; Production Test to Start analysis
Sign-up for FX Energy Reports Gas Flow at Tuchola-3K Well; Production Test to Start investment picks
2013/4/29
Central European Media Selling $174 Million of Class A Stock
Central European Media Enterprises Ltd.
View more Central European Media Selling $174 Million of Class A Stock analysis
Sign-up for Central European Media Selling $174 Million of Class A Stock investment picks
2013/4/29
SAIC Begins Work on Integrated Airport Management System at Denver International Airport
Company to Integrate One of the First Airport Management Systems of its Kind MCLEAN, Va.
View more SAIC Begins Work on Integrated Airport Management System at Denver International Airport analysis
Sign-up for SAIC Begins Work on Integrated Airport Management System at Denver International Airport investment picks
2013/4/29
Al's Emporium: Pets on Food Stamps
If you believe the economy is improving, you've likely never met someone who still can't afford a can of cat food.
View more Al's Emporium: Pets on Food Stamps analysis
Sign-up for Al's Emporium: Pets on Food Stamps investment picks
2013/4/29
Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule
SAN ANTONIO , April 29, 2013 /PRNewswire/ -- Pioneer Energy Services (NYSE: PES) today announced that it will release its first quarter 2013 financial results before the market opens on Tuesday, April 30.
View more Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule analysis
Sign-up for Pioneer Energy Services Announces First Quarter 2013 Earnings Release and Conference Call Schedule investment picks
2013/4/29
pSivida Reports ILUVIEN® Available in UK
pSivida Corp.
View more pSivida Reports ILUVIEN® Available in UK analysis
Sign-up for pSivida Reports ILUVIEN® Available in UK investment picks
2013/4/29
Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
JERUSALEM , April 29, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ), a developer of oral delivery systems of drugs currently administered by injection, announced today that its abstract, entitled "Oral insulin capsules toward management of Type 1 diabetes mellitus," will be presented at the Global Technology Community Diabetes Summit 2013.
View more Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013 analysis
Sign-up for Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013 investment picks
2013/4/29
Rent-A-Center Announces Intention to Offer $250 Million in Senior Unsecured Notes
Rent-A-Center, Inc. (the “Company”) (NASDAQ/NGS: RCII) announced today that it intends, subject to market conditions, to offer $250 million in aggregate principal amount of senior unsecured notes due 2021 (the “notes”) in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Company intends to use the net proceeds of the offering to repay $46 million of the revolving loans outstanding under its revolving credit facility and apply the remainder to accelerated common stock repurchases as market conditions permit and, to the extent not so applied, for general corporate purposes.
View more Rent-A-Center Announces Intention to Offer $250 Million in Senior Unsecured Notes analysis
Sign-up for Rent-A-Center Announces Intention to Offer $250 Million in Senior Unsecured Notes investment picks
2013/4/29
Luxottica CEO Sees "Good" Growth in 2013 as Sunglass Use Grows
MILAN --
View more Luxottica CEO Sees "Good" Growth in 2013 as Sunglass Use Grows analysis
Sign-up for Luxottica CEO Sees "Good" Growth in 2013 as Sunglass Use Grows investment picks
2013/4/29
Penske Automotive Reports Record Results
Penske Automotive Group, Inc. (NYSE:PAG) , an international automotive retailer, announced today the highest income and earnings per share in company history.
View more Penske Automotive Reports Record Results analysis
Sign-up for Penske Automotive Reports Record Results investment picks
2013/4/29
Eaton 1st-Quarter Net Up 22% on Acquisition; Sales Miss Street View
Eaton Corp.'s (ETN) first-quarter earnings rose 22% with the help of its Cooper Industries acquisition, but revenue growth fell short of Wall Street views as global demand continued to slow.
View more Eaton 1st-Quarter Net Up 22% on Acquisition; Sales Miss Street View analysis
Sign-up for Eaton 1st-Quarter Net Up 22% on Acquisition; Sales Miss Street View investment picks
2013/4/29
Endeavour Silver Implements Cost Reductions, Revises 2013 Financial Plan to Reflect Lower Precious Metal Prices
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0869540001&sourceType=1 http://www.ccnmatthews.com/logos/20061115-edr2.gif VANCOUVER, BRITISH COLUMBIA --
View more Endeavour Silver Implements Cost Reductions, Revises 2013 Financial Plan to Reflect Lower Precious Metal Prices analysis
Sign-up for Endeavour Silver Implements Cost Reductions, Revises 2013 Financial Plan to Reflect Lower Precious Metal Prices investment picks
2013/4/29
Ultrapetrol Appoints New CFO
NASSAU, Bahamas, April 29, 2013 (GLOBE NEWSWIRE) -- Ultrapetrol (Bahamas) Limited (Nasdaq:ULTR) , an industrial transportation company serving marine transportation needs in three markets (River Business, Offshore Supply Business and Ocean Business), announced today the appointment of Ms.
View more Ultrapetrol Appoints New CFO analysis
Sign-up for Ultrapetrol Appoints New CFO investment picks
2013/4/29
RainDance Technologies Closes $20 Million Series E Financing
RainDance Technologies, Inc., the Digital Biology™ Company, today announced the closing of a $20 million Series E financing round.
View more RainDance Technologies Closes $20 Million Series E Financing analysis
Sign-up for RainDance Technologies Closes $20 Million Series E Financing investment picks
2013/4/29
Professional Diversity Network Announces Share Repurchase Program
CHICAGO, April 29, 2013 (GLOBE NEWSWIRE) -- Professional Diversity Network, Inc. (Nasdaq:IPDN) , a developer and operator of online networks dedicated to serving diverse professionals in the United States and providing them with access to employment opportunities, today announced that its Board of Directors has authorized a share repurchase program pursuant to which the Company may repurchase up to $1 million of its outstanding common stock.
View more Professional Diversity Network Announces Share Repurchase Program analysis
Sign-up for Professional Diversity Network Announces Share Repurchase Program investment picks
2013/4/29
Alimera Sciences Announces ILUVIEN® Now Available In U.K.
Simple Patient Access Scheme has been submitted to NICE for rapid review       ATLANTA , April 29, 2013 /PRNewswire/ -- Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN ® , the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema (DME), is now available in the United Kingdom .
View more Alimera Sciences Announces ILUVIEN® Now Available In U.K. analysis
Sign-up for Alimera Sciences Announces ILUVIEN® Now Available In U.K. investment picks
2013/4/29
DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders
QUEBEC CITY , April 29, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) reminds shareholders to attend its Annual and Special Meeting of Shareholders to be held today, April 29 th , at 3pm EDT , at the offices of McCarthy Tetrault, 1000 de la Gauchetière Street West, Suite 2500, Montreal, Quebec , H3B 0A2.
View more DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders analysis
Sign-up for DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders investment picks
2013/4/29
DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders
DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders Canada NewsWire QUEBEC CITY, April 29, 2013 /CNW Telbec/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) reminds shareholders to attend its Annual and Special Meeting of Shareholders to be held today, April 29 th , at 3pm EDT , at the offices of McCarthy Tetrault, 1000 de la Gauchetière Street West, Suite 2500, Montreal , Quebec , H3B 0A2.
View more DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders analysis
Sign-up for DiagnoCure's Update Presentation during the Annual and Special Meeting of Shareholders investment picks
2013/4/29
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Merck & Co., Inc. (NYSE: MRK) , known as MSD outside the United States and Canada (“Merck”), and Pfizer Inc. (NYSE:PFE) today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer’s ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.
View more Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes analysis
Sign-up for Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: LMP Real Estate Income Fund Inc. Portfolio Composition as of March 31, 2013 to Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.